CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $201,787
- in 1 filing
Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-01 | MOORE JOHN R General Counsel | Option exercise | +5,208 | 5,208 | ||
| 2024-05-01 | MOORE JOHN R General Counsel | Option exercise · Restricted Stock Units | −5,208 | 5,209 | ||
| 2024-05-01 | Carruthers R Michael Chief Financial Officer | Option exercise | +5,208 | 37,387 | ||
| 2024-05-01 | Carruthers R Michael Chief Financial Officer | Option exercise · Restricted Stock Units | −5,208 | 5,209 | ||
| 2024-05-01 | Derakhshan Behrad Chief Business Officer | Option exercise | +5,208 | 15,140 | ||
| 2024-05-01 | Derakhshan Behrad Chief Business Officer | Option exercise · Restricted Stock Units | −5,208 | 5,209 | ||
| 2024-05-01 | Russell Alan J Chief Scientific Officer | Option exercise | +5,208 | 8,814 | ||
| 2024-05-01 | Russell Alan J Chief Scientific Officer | Option exercise · Restricted Stock Units | −5,208 | 5,209 | ||
| 2024-05-01 | Donovan Joanne M. CMO | Option exercise | +10,417 | 23,579 | ||
| 2024-05-01 | Donovan Joanne M. CMO | Option exercise · Restricted Stock Units | −10,417 | 10,417 | ||
| 2024-05-01 | KOCH KEVIN President and CEO | Option exercise | +10,417 | 17,630 | ||
| 2024-05-01 | KOCH KEVIN President and CEO | Option exercise · Restricted Stock Units | −10,417 | 10,417 | ||
| 2024-02-09 | MOORE JOHN R General Counsel | Option exercise 10b5-1 | +8,029 | $1.93 | $15K | 8,029 |
| 2024-02-09 | MOORE JOHN R General Counsel | Sale 10b5-1 | −8,029 | $20.01 | $161K | 0 |
| 2024-02-09 | MOORE JOHN R General Counsel | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,029 | 93,162 | ||
| 2024-02-09 | Derakhshan Behrad Chief Business Officer | Option exercise 10b5-1 | +4,800 | $1.93 | $9K | 11,820 |
| 2024-02-09 | Derakhshan Behrad Chief Business Officer | Sale 10b5-1 | −4,800 | $20.04 | $96K | 7,020 |
| 2024-02-09 | Derakhshan Behrad Chief Business Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,800 | 145,017 | ||
| 2024-02-08 | MOORE JOHN R General Counsel | Option exercise 10b5-1 | +3,813 | $1.93 | $7K | 3,813 |
| 2024-02-08 | MOORE JOHN R General Counsel | Sale 10b5-1 | −3,813 | $20.01 | $76K | 0 |
Page 14 of 26 · 509 trades